Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Madrigal Pharmaceuticals, Inc.

http://www.madrigalpharma.com/

Latest From Madrigal Pharmaceuticals, Inc.

Helixmith’s Plasmid DNA Therapeutic Moves Forward With New Formulation

South Korea's Helixmith reaches a milestone with a US FDA nod to use a new in-house developed formulation for its plasmid DNA therapeutic Engensis, said to be more suited to mass production, in its upcoming Phase III trials for diabetic peripheral neuropathy.

South Korea Gene Therapy

Phase III Data In Suspected NASH Boost Madrigal’s Profile, But Bigger Data To Come

Resmetirom, Madrigal’s THRβ agonist, demonstrates safety and tolerability, and succeeds on secondary efficacy endpoints in a study serving as a precursor to the firm’s pivotal Phase III trial.

Clinical Trials Drug Approval Standards

NASH Updates: Intercept Moves Toward Re-Filing, Madrigal De-Risks Phase III

AASLD Briefing: While working on new biopsy reviews to address CRL, Intercept also might consider filing for approval in cirrhotic patients if REVERSE study succeeds. Plus other updates on NASH programs.

Clinical Trials Drug Approval Standards

Akero Sees Across-The-Board NASH Benefit With Efruxifermin, But Faces Competition

At EASL 2021, Akero presented efruxifermin data showing benefit in cirrhotic NASH patients and strong liver fat reduction, but may be challenged in the FGF21 analog class by 89Bio.

Business Strategies Clinical Trials
See All

Company Information

  • Other Names / Subsidiaries
    • Via Pharmaceuticals, Inc.
UsernamePublicRestriction

Register